Yeh, Y.-S., Evans, T. D., Iwase, M., Jeong, S.-J., Zhang, X., Liu, Z., Park, A., Ghasemian, A., Dianati, B., Javaheri, A., Kratky, D., Kawarasaki, S., Goto, T., Zhang, H., Dutta, P., Schopfer, F. J., Straub, A. C., Cho, J., Lodhi, I. J., & Razani, B. (2025). Identification of lysosomal lipolysis as an essential noncanonical mediator of adipocyte fasting and cold-induced lipolysis. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci185340

Almeida, F. C., Patra, K., Giannisis, A., Niesnerova, A., Nandakumar, R., Ellis, E., Oliveira, T. G., & Nielsen, H. M. (2024). APOE genotype dictates lipidomic signatures in primary human hepatocytes. Journal of Lipid Research, 65(2), 100498. https://doi.org/10.1016/j.jlr.2024.100498

Huang, P.-P., Zhu, W.-Q., Xiao, J.-M., Zhang, Y.-Q., Li, R., Yang, Y., Shen, L., Luo, F., Dai, W., Lian, P.-A., Tang, Y.-X., Ran, J.-L., & Huang, X.-S. (2022). Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.935362

Hamilton, J. A., Huang, N., Ng, J., Gubler, T., Khuda, R., Deckelbaum, R. J., & Chang, C. L. (2022). C-13 NMR spectroscopic characterization and distinction of EPA and DHA in lipid emulsions. Atherosclerosis, 355, 91. https://doi.org/10.1016/j.atherosclerosis.2022.06.501

Kirk, L. M., Waits, C. M. K., Bashore, A. C., Dosso, B., Meyers, A. K., Renaldo, A. C., DePalma, T. J., Simms, K. N., Hauser, N., Chuang Key, C.-C., McCall, C. E., Parks, J. S., Sergeant, S., Langefeld, C. D., Skardal, A., & Rahbar, E. (2022). Exploiting three-dimensional human hepatic constructs to investigate the impact of rs174537 on fatty acid metabolism. PLOS ONE, 17(1), e0262173. https://doi.org/10.1371/journal.pone.0262173